Posts
September 22 2017
DelMar Pharmaceuticals announced the closing of their Registered Direct offering in the amount of $10,000,000. EG&S acted as counsel to the Placement Agent.
September 20 2017
Draper Oakwood Technology Acquisition, Inc. announced the closing of its initial public offering in the amount of $50,000,000. EG&S acted as counsel to Draper Oakwood.
September 19 2017
Douglas Ellenoff, Stuart Neuhauser and Matthew Gray; members of the Firm, were invited by Strafford to participate on a Webinar titled:Special Purpose Acquisition Companies: Structuring IPOS and Facilitating Future Mergers and Acquisitions. The panel discussed the disclosure and operational requirements particular to SPACs, the timing and valuation parameters relating to SPAC target acquisitions and issues that may arise in a SPAC’s initial business combination. The panel also discussed the typical pricing of SPAC securities and trust accounts.
September 19 2017
Rennova Health, Inc. announced the closing of their PIPE offering in the amount of $6,412,136. EG&S acted as counsel to the Investor.
September 18 2017
STRATA Skin Science Inc. announced the closing of their Registered Direct offering in the amount of $40,652,594. EG&S acted as counsel to the Lead Investor.
September 15 2017
Moleculin Biotech, Inc. announced the closing of their At the Market offering. EG&S acted as counsel to the Placement Agent.
September 12 2017
Inspyr Therapeutics Inc. announced the closing of their PIPE & Exchange offering in the amounts of $320,000.00 & $2,504,812. EG&S acted as counsel to the Investor.
August 28 2017
Cel-Sci Corporation announced the closing of their Registered Direct offering in the amount of $3,500,000. EG&S acted as counsel to the Placement Agent.